Company / Cost of Revenue
Coherus Oncology, Inc. Cost of Revenue History
FY2019-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$17.1M
FY2019
5-year range
$17.1M / $17.1M
FY2019-FY2019
Trend
-
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$17M in FY2019.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $17.1M | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026